Diagnostic Yield of Exome Sequencing in Fetuses With Multisystem Malformations: Systematic Review and Meta-analysis

dc.contributor.authorPauta, Montse
dc.contributor.authorMartínez Portilla, Raigam J.
dc.contributor.authorBorrell, Antoni
dc.date.accessioned2024-10-25T16:57:16Z
dc.date.available2024-10-25T16:57:16Z
dc.date.issued2022-12-01
dc.date.updated2024-10-25T16:57:16Z
dc.description.abstractObjective: To determine the diagnostic yield of exome sequencing (ES) above that of chromosomal microarray analysis (CMA) or karyotyping in fetuses with multisystem structural anomalies (at least two major anomalies in different anatomical systems). Method: This was a systematic review conducted in accordance with PRISMA guidelines. Searching PubMed, Web of Knowledge and Cochrane database, we identified studies describing ES, whole-genome and/or next-generation sequencing in fetuses with multisystem malformations. Included were observational studies involving five or more eligible fetuses. A fetus was eligible for inclusion if it had at least two major anomalies of different anatomical systems and a negative CMA or karyotyping result. Only positive variants classified as likely pathogenic or pathogenic determined to be causative of the fetal phenotype were considered. A negative CMA or karyotype result was treated as the reference standard. The diagnostic yield of the primary outcome was calculated by single-proportion analysis using random-effects modeling. A subgroup analysis was performed to compare the diagnostic yield of the solo approach (fetus alone sequenced) with that of the trio approach (fetus and both parents sequenced). Results: Seventeen articles with data on ES diagnostic yield, including 694 individuals with multisystem malformations, were identified. Overall, a pathogenic or likely pathogenic variant potentially causative of the fetal phenotype was found in 213 fetuses, giving a 33% (95% CI, 27–40%) incremental yield of ES. A stratified analysis showed similar diagnostic yields of ES using the solo approach (30%; 95% CI, 11–52%) and the trio approach (35%; 95% CI, 26–44%). Conclusions: ES applied in fetuses with multisystem structural anomalies was able to identify a potentially causative gene when CMA or karyotyping had failed to do so in an additional one-third of cases. No differences were observed between the solo and trio approaches for ES. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec729059
dc.identifier.issn0960-7692
dc.identifier.pmid35041238
dc.identifier.urihttps://hdl.handle.net/2445/216063
dc.language.isoeng
dc.publisherJohn Wiley & Sons
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1002/uog.24862
dc.relation.ispartofUltrasound in Obstetrics & Gynecology, 2022, vol. 77, num.12, p. 711-712
dc.relation.urihttps://doi.org/10.1002/uog.24862
dc.rightscc-by-nc-nd (c) Pauta, Montse et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0*
dc.sourceArticles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
dc.subject.classificationMalformacions del fetus
dc.subject.classificationEmbaràs
dc.subject.classificationGenoma humà
dc.subject.otherFoetus malformations
dc.subject.otherPregnancy
dc.subject.otherHuman genome
dc.titleDiagnostic Yield of Exome Sequencing in Fetuses With Multisystem Malformations: Systematic Review and Meta-analysis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
256075.pdf
Mida:
840.21 KB
Format:
Adobe Portable Document Format